Clinical trial
Tranexamic Acid : Nebulization vs IV Route for Hemoptysis
NCT07212452 is registered in ClinicalTrials.gov with University of Health Sciences Lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tranexamic Acid : Nebulization vs IV Route for Hemoptysis
- Lead sponsor
- University of Health Sciences Lahore
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 1, 2025
- Completion date
- October 31, 2025
- Enrollment
- 172 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemoptysis, nebulization, tranexamic acid